Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Available NCT05683470

Expanded Access to RBS2418

Conditions: Expanded Access

Sex: Female
Sponsor: Riboscience, LLC.

Summary

This is an expanded access treatment protocol designed to provide access of RBS2418 to a single patient with pancreatic cancer.

Eligibility Criteria

Inclusion Criteria:The patient is willing and able to provide informed consent. Only the patient for whom this clinical study/experimental treatment was designed will be given the investigational drug under the treatment of the PI. No other patient is authorized to participate in or to receive treatment under this treatment protocol.Exclusion Criteria:Not applicable

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05683470). StuddyBuddy aggregates publicly available trial information.